Welcome to AngioPredict

  • Anti-Angiogenic Agents For Cancer Therapy Anti-Angiogenic Agents For Cancer Therapy

ANGIOPREDICT - an FP7-funded project enabling personalised medicine for patients with metastatic colorectal cancer.

About AngioPredict

In ANGIOPREDICT, academic cancer biologists and industry-based biotechnology researchers will work together with clinicians to identify biomarkers to predict whether individual metastatic colorectal cancer patients will respond positively to AvastinĀ® combination therapy. Diagnostic tests using these biomarkers will also be developed to provide clinicians with the means to predict patient treatment responses in the future.
 

Recently Published

 

Project Newsletter Vol III